Archive for dem

DEM BioPharma Announces Poster Presentation Featuring DEM301 at the 2026 ASCO Gastrointestinal Cancers Symposium

January 7, 2026

‘Don’t eat me’ upstart taps Takeda vet on path to the clinic

October 3, 2022

DEM BioPharma Establishes Leadership Team with Appointment of Nenad Grmusa as CEO and Christophe Quéva, Ph.D., as CSO

September 27, 2022